Mar 17, 01:19 PM

Stada Plans IPO Launch as Soon as Wednesday, Amid Potential September Delay; KKR and Warburg Pincus Offer Nearly €90 for Gerresheimer

German pharmaceutical firm Stada is preparing to launch its initial public offering (IPO) as early as Wednesday, according to sources familiar with the matter. This move is seen as a significant test for Europe's equity markets. However, reports indicate that Stada's private equity owners are considering delaying the IPO until September. The company has stated that it is evaluating all options for its ownership structure, including the possibility of an IPO. In a separate development, KKR and Warburg Pincus have made an offer for Gerresheimer at nearly €90 per share.

#Stada #Europe #KKR #Warburg Pincus #Gerresheimer

Written with ChatGPT (GPT-4o mini).

Sources

Reuters Health@Reuters_Health
1 year ago
German pharmaceutical firm Stada said on Tuesday it was generally evaluating all options for its further ownership, including a possible initial public offering. https://t.co/LuTyh1mmaS https://t.co/LuTyh1mmaS
Bloomberg@business
1 year ago
Stada's private equity owners are pushing back a planned IPO of the German drugmaker until September https://t.co/S9ZULSBu8Q
De Tijd@tijd
1 year ago
'Duitse farmagroep Stada, bekend van EG, dicht bij startschot beursgang' https://t.co/y4wsfsdmBx https://t.co/TM8jjSKWmV

Stada Plans IPO Launch as Soon as Wednesday, Amid Potential September Delay; KKR and Warburg Pincus Offer Nearly €90 for Gerresheimer

Sources

Additional media

Similar Stories